Algorithmiq - About the company
Algorithmiq is a series B company based in Helsinki (Finland), founded in 2020 by Sabrina Maniscalco and Boris Sokolov. It operates as a Developer of quantum algorithms for chemistry and life science applications. Algorithmiq has raised $42.4M in funding from investors like Cassa depositi e prestiti Group, United Ventures and Inventure. The company has 11 active competitors, including 4 that are funded. Its top competitors include companies like Qunova Computing, Quantum Biosystems and Allosteric Bioscience.
Company Details
Developer of quantum algorithms for chemistry and life science applications. The company develops algorithms that integrate classical and quantum computers. These algorithms address complex problems in quantum chemistry. They also offer solutions for drug discovery and development, targeting rare diseases. The company publishes research in peer-reviewed journals.
- Website
- algorithmiq.fi
- Email ID
- *****@algorithmiq.fi
Key Metrics
Founded Year
2020
Location
Helsinki, Finland
Stage
Series B
Total Funding
$42.4M in 3 rounds
Latest Funding Round
Investors
Ranked
1st among 11 active competitors
Employee Count
54 as on Jun 30, 2026
Sign up to download Algorithmiq's company profile
Algorithmiq's funding and investors
Algorithmiq has raised a total funding of $42.4M over 3 rounds. Its first funding round was on Feb 02, 2022. Its latest funding round was a Series B round on May 11, 2026 for $*****. 3 investors participated in its latest round. Algorithmiq has 10 institutional investors and 4 angel investors.
Here is the list of recent funding rounds of Algorithmiq:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 11, 2026 | 4399673 | Series B | 4047551 | 8311931 | 2690602 | 3404647 |
Jun 02, 2023 | 5450220 | Series A | 8460325 | 3934828 | 9133864 | |
Feb 02, 2022 | 1143771 | Seed | 5102961 | 1993286 | 5417889 |
View details of Algorithmiq's funding rounds and investors
Algorithmiq's founders and board of directors
Founder? Claim ProfileThe founders of Algorithmiq are Sabrina Maniscalco and Boris Sokolov. Sabrina Maniscalco is the CEO of Algorithmiq.
Here are the details of Algorithmiq's key team members:
- Sabrina Maniscalco: Co-Founder & CEO of Algorithmiq. Contact Info: 1 email address
- Boris Sokolov: Co-Founder of Algorithmiq. Contact Info: 1 email address
View details of Algorithmiq's Founder profiles and Board Members
Algorithmiq's employee count trend
Algorithmiq has 54 employees as of Jun 26. Here is Algorithmiq's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Algorithmiq's Competitors and alternates
Top competitors of Algorithmiq include Qunova Computing, Quantum Biosystems and Allosteric Bioscience. Here is the list of Top 10 competitors of Algorithmiq, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Algorithmiq 2020, Helsinki (Finland), Series B | Developer of quantum algorithms for chemistry and life science applications | $42.4M | 57/100 | |
2nd | Qunova Computing 2021, Yuseong District (South Korea), Series A | Provider of AI-powered quantum computing solutions for the life science sector | $10M | 49/100 | |
3rd | Quantum Biosystems 2013, Osaka (Japan), Series C | Developing DNA sequencers based on quantum mechanics | $35M | 39/100 | |
4th | Allosteric Bioscience 2021, New York City (United States), Unfunded | Provider of a platform to create treatments for aging and longevity | - | - | 33/100 |
5th | Polaris Quantum Biotech 2019, Durham (United States), Seed | Developer of a AI and quantum computing-based drug discovery platform | $2.48M | 31/100 | |
6th | Qulab 2017, Los Angeles (United States), Deadpooled | Provider of computational methods for molecular drug design | - | 28/100 | |
7th | GTN 2017, New York City (United States), Deadpooled | Provider of quantum computing-based software for drug discovery | $2.85M | 27/100 | |
8th | QClairvoyance 2024, Secunderabad (India), Unfunded | Provider of quantum computing solutions | - | - | 23/100 |
9th | MagneSensors 1997, San Diego (United States), Deadpooled | Developer of magnetic detection systems for clinical diagnostics & drug delivery applications | - | 21/100 | |
10th | Developer of quantum algorithms and software for industrial applications | - | - | 20/100 |
Looking for more details on Algorithmiq's competitors? Click here to see the top ones
Algorithmiq's Investments and acquisitions
Algorithmiq has made no investments or acquisitions yet.
Reports related to Algorithmiq
Here is the latest report on Algorithmiq's sector:
News related to Algorithmiq
Media has covered Algorithmiq for a total of 6 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.
•
•
Algorithmiq Raises €18 Million in Funding, Moves Global HQ to MilanEU-Startups•May 11, 2026•Algorithmiq, United Ventures, Inventure, Cassa depositi e prestiti Group and 1 other
•
Algorithmiq Wins $2 Million Q4Bio Prize for Quantum-Driven Cancer Therapy SimulationQuantum Computing Report•Apr 17, 2026•Algorithmiq, IBM, Advisors Capital
•
•
•
•
NVIDIA partners with Algorithmiq to advance quantum computingChannelLife•Nov 19, 2024•Algorithmiq, Nvidia
•
•
•
Are you a Founder ?
FAQs about Algorithmiq
Explore our recently published companies